Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Petros Pharmaceuticals, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
8-K
| Quarterly results |
| 08/15/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 07/13/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...|
Docs:
|
"CERTIFICATE OF DESIGNATIONS OF CONVERTIBLE PREFERRED STOCK OF",
"Form of Warrant Neither the issuance and sale of the securities represented by this certificate nor the securities into which these securities are exercisable have been registered under the securities act of 1933, as amended, or applicable state securities laws. The securities may not be offered for sale, sold, transferred or assigned in the absence of an effective registration statement for the securities under the securities act of 1933, as amended, or an opinion of counsel to the holder , in a form reasonably acceptable to the company, that registration is not required under said act or unless sold or eligible to be sold pursuant to rule 144 or rule 144a under said act. Notwithstanding the foregoing, the securities may be pledged in connection with a bona fide margin account or other lo...",
"RECITALS",
"Registration Rights Agreement",
"Petros Pharmaceuticals Announces Capital Raise of $15 million" |
|
| 11/30/2022 |
8-K
| Quarterly results |
| 11/15/2022 |
8-K
| Quarterly results |
| 08/15/2022 |
8-K
| Quarterly results |
| 07/28/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 06/24/2022 |
8-K
| Quarterly results |
| 04/26/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 04/04/2022 |
8-K
| Quarterly results |
| 03/04/2022 |
8-K
| Quarterly results |
| 01/24/2022 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
| 01/21/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"PLEASE NOTE: CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SETTLEMENT AGREEMENT This SETTLEMENT AGREEMENT, dated as of January 18, 2022, is entered into by and between METUCHEN PHARMACEUTICALS LLC, a Delaware limited liability company and VIVUS LLC, a Delaware limited liability company and formerly VIVUS, Inc. . Metuchen and VIVUS are collectively referred to as the “ Parties ” and each a “ Party .” WHEREAS, Metuchen and VIVUS are parties to that certain License and Commercialization Agreement, dated September 30, 2016 , pursuant to which VIVUS granted to Metuchen an exclusive license in the Territory for, among other things, the development and commercialization of the therapeuti...",
"PROMISSORY NOTE",
"Security Agreement, between Metuchen Pharmaceuticals LLC and VIVUS LLC, a Delaware limited liability company",
"Cover Page Interactive Data File (embedded within the Inline XBRL document)" |
|
| 12/27/2021 |
8-K
| Quarterly results |
| 12/23/2021 |
8-K
| Quarterly results |
| 12/01/2021 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"COMMON STOCK PURCHASE WARRANT PETROS PHARMACEUTICALS, INC. Warrant Shares: _______ Initial Exercise Date: December [•], 2021 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on [•], [•] [1] but not thereafter, to subscribe for and purchase from Petros Pharmaceuticals, Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 .           Definitions . C...",
"Petros Pharmaceuticals, Inc. 1185 Avenue of the Americas, 3rd Floor New York, New York 10036",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of November 29, 2021, between Petros Pharmaceuticals, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act of 1933, as amended as to the Registered Shares and an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4 thereof and/or Regulation D thereunder as to the Unregistered Shares and Warrants , the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully de...",
"Petros Pharmaceuticals Announces $10 Million Offering Investors included the company's largest shareholder NEW YORK, Nov. 30, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. , a leading provider of therapeutics for men's health, today announces that it has entered into definitive agreements with the company's largest investor and other existing investors, for the purchase and sale of 3,333,333 shares of Petros Pharmaceuticals' common stock, at a purchase price of $3.00 per share. The company will sell 2,153,333 shares in a registered direct offering and the remaining 1,180,000 shares will be sold in a private placement. Petros Pharmaceuticals has also agreed to issue the investors unregistered warrants to acquire 2,500,000 shares of common stock at an exercise price of $3.50 per share, e..." |
|
| 11/17/2021 |
8-K
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 Interactive Data |
| 10/15/2021 |
8-K
| Quarterly results |
| 04/06/2021 |
8-K
| Quarterly results |
| 02/25/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/25/2021 |
8-K
| Quarterly results |
| 01/19/2021 |
8-K
| Quarterly results |
| 12/15/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/10/2020 |
8-K
| Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits |
| 12/02/2020 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Material Modifications to Rig... |
|
|